XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.24.3

Note 10 - Derivative Liabilities | 3 Months Ended
--- | ---
Oct. 31, 2024
Notes to Financial Statements |
Derivatives and Fair Value [Text Block] |
NOTE 10: | DERIVATIVE LIABILITIES
On August 19, 2022, the Company issued replacement warrants (each, a “Replacement Warrant”) in connection with the UEX Acquisition. The Replacement Warrants are accounted for as derivative liabilities as the exercise prices of the Replacement Warrants are denominated in Canadian dollars which differs from our functional currency. As at October 31, 2024, there were no Replacement Warrants outstanding. The movement in derivative liabilities during the period is as follows:
Balance, July 31, 2024 |  | $ | 3,030 |
Exercise of Replacement Warrants |  |  | (1,324 | )
Change in fair value during the period |  |  | (1,706 | )
Balance, October 31, 2024 |  | $ | - |

X
- Definition The entire disclosure for derivatives and fair value of assets and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/815/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/820/tableOfContent + Details
Name: | us-gaap_DerivativesAndFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration